The blood sugar-lowering drug metformin changes how cancer stem cells use and metabolize energy, making them more vulnerable to a new treatment.
The blood sugar-lowering drug metformin changes how cancer stem cells use and metabolize energy, making them more vulnerable to a new treatment.